Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Karolinska Institutet
Before start of SCIT, with Alutard pollenextract/s from " Allergologisk Laboratorium Köbenhavn" (ALK), and after one year of treatment, immunoglobulin E (IgE)-antibody levels towards the crude allergen and important allergen components in birch and grasspollen (timothy) will be measured in blood. While IgE- antibodies are considered to be an indicator of allergy IgG- and IgG4-antibodies are considered to be "blocking" antibodies in IgE-mediated allergy. Therefore the investigators will measure the IgG- and IgG4-antibody levels to crude allergens and applicable allergen components before start, when maintenance dose is reached (after 6 months) and after one year of treatment. In order to evaluate quality of life, a validated form (DISABKIDS) will be used. Symptom score will be rated by a validated form (LILA). The need for medication to treat allergic rhinitis and asthma will be assessed using questionnaires. A conjunctival provocation with the applicable allergen(s) will be performed before start of SCIT and after one year of treatment.
Age
6–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Seasonal Rhinoconjunctivitis caused by grass and/or birch pollen allergy
Insufficient clinical effect of symptomatic treatment (antihistamine, nasal corticosteroids)
IgE antibodies to grass and/or birch pollen antigens